BioDelivery Sciences International Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$105.5M
Lead Investor(s):William Blair & Company, L.L.C.

Estimated Revenue & Financials

  • BioDelivery Sciences International's estimated annual revenue is currently $5.6M per year.(?)
  • BioDelivery Sciences International received $50.0M in venture funding in May 2018.
  • BioDelivery Sciences International's estimated revenue per employee is $25,622
  • BioDelivery Sciences International's total funding is $105.5M.

Employee Data

  • BioDelivery Sciences International has 217 Employees.(?)
  • BioDelivery Sciences International grew their employee count by 7% last year.
  • BioDelivery Sciences International currently has 4 job openings.

BioDelivery Sciences ("BDSI"®) is a specialty pharmaceutical company with a focus in the areas of pain management and addiction medicine. We are utilizing our novel and proprietary BioErodible MucoAdhesive (BEMA®) and other drug delivery technologies to develop and commercialize, either on our own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs.